Literature DB >> 26527653

p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis.

Mehrnoosh Tashakori1, Yun Zhang2, Shunbin Xiong2, M James You3, Guillermina Lozano4.   

Abstract

UNLABELLED: Mdm4 negatively regulates the p53 tumor suppressor. Mdm4 loss in mice leads to an embryonic lethal phenotype that is p53-dependent. Biochemical studies indicate that Mdm4 also binds p73, a member of the p53 family, with higher affinity than p53. In this study, the significance of the Mdm4 and p73 interaction in vivo during embryogenesis and tumorigenesis was examined. The data revealed that p73 loss did not rescue either the early Mdm4-deficient embryonic lethality or the runted phenotype of Mdm4(Δ2/Δ2) p53(+/-) embryos. Furthermore, studies in the developing central nervous system wherein both genes have prominent roles indicated that loss of p73 also did not rescue the Mdm4-null brain phenotype as did p53 loss. This p53 dependency occurred despite evidence for p73-specific transcriptional activity. In tumor studies, the combination of Mdm4 overexpression and p73 loss did not alter survival of mice or the tumor spectrum as compared with Mdm4 overexpression alone. In summary, these data demonstrate that the Mdm4-p73 axis cannot override the dominant role of p53 in development and tumorigenesis. IMPLICATIONS: Genetic characterization of the Mdm4 and p73 interaction during development and tumorigenesis suggests new insight into the role of p53 family members, which may influence treatment options for patients. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26527653      PMCID: PMC4715923          DOI: 10.1158/1541-7786.MCR-15-0346

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  76 in total

1.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

3.  Inactivation of the p53-homologue p73 by the mdm2-oncoprotein.

Authors:  M Dobbelstein; S Wienzek; C König; J Roth
Journal:  Oncogene       Date:  1999-03-25       Impact factor: 9.867

Review 4.  Translating p53 into the clinic.

Authors:  Chit Fang Cheok; Chandra S Verma; José Baselga; David P Lane
Journal:  Nat Rev Clin Oncol       Date:  2010-10-26       Impact factor: 66.675

5.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

6.  Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.

Authors:  S Ichimiya; Y Nimura; H Kageyama; N Takada; M Sunahara; T Shishikura; Y Nakamura; S Sakiyama; N Seki; M Ohira; Y Kaneko; F McKeon; D Caput; A Nakagawara
Journal:  Med Pediatr Oncol       Date:  2001-01

7.  Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly.

Authors:  Douglas B Gould; F Campbell Phalan; Guido J Breedveld; Saskia E van Mil; Richard S Smith; John C Schimenti; Umberto Aguglia; Marjo S van der Knaap; Peter Heutink; Simon W M John
Journal:  Science       Date:  2005-05-20       Impact factor: 47.728

8.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

9.  Familial porencephaly.

Authors:  R A Berg; K A Aleck; A M Kaplan
Journal:  Arch Neurol       Date:  1983-09

Review 10.  p73: Friend or foe in tumorigenesis.

Authors:  Gerry Melino; Vincenzo De Laurenzi; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  5 in total

Review 1.  Zinc and zinc-containing biomolecules in childhood brain tumors.

Authors:  Jan Hrabeta; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Sona Krizkova; Vojtech Adam
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

2.  p53 pathway is involved in cell competition during mouse embryogenesis.

Authors:  Guoxin Zhang; Yinyin Xie; Ying Zhou; Cong Xiang; Lai Chen; Chenxi Zhang; Xiaoshuang Hou; Jiong Chen; Hui Zong; Geng Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

3.  TAp73 regulates ATP7A: possible implications for ageing-related diseases.

Authors:  Piervito Lopriore; Nazzareno Capitanio; Emanuele Panatta; Nicola Di Daniele; Alessandra Gambacurta; Gerry Melino; Ivano Amelio
Journal:  Aging (Albany NY)       Date:  2018-12-08       Impact factor: 5.682

Review 4.  Structural diversity of p63 and p73 isoforms.

Authors:  Christian Osterburg; Volker Dötsch
Journal:  Cell Death Differ       Date:  2022-03-21       Impact factor: 12.067

Review 5.  The long and the short of it: the MDM4 tail so far.

Authors:  Sue Haupt; Javier Octavio Mejía-Hernández; Reshma Vijayakumaran; Simon P Keam; Ygal Haupt
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.